p38 mitogen-activated protein kinase and pain.
Glial cells
Pain
p38 MAP kinase
Journal
Life sciences
ISSN: 1879-0631
Titre abrégé: Life Sci
Pays: Netherlands
ID NLM: 0375521
Informations de publication
Date de publication:
01 Sep 2020
01 Sep 2020
Historique:
received:
27
02
2020
revised:
23
05
2020
accepted:
28
05
2020
pubmed:
3
6
2020
medline:
1
9
2020
entrez:
3
6
2020
Statut:
ppublish
Résumé
Inflammatory and neuropathic pain is initiated by tissue inflammation and nerve injury, respectively. Both are characterized by increased activity in the peripheral and central nervous system, where multiple inflammatory cytokines and other active molecules activate different signaling pathways that involve in the development and/or maintenance of pain. P38 mitogen-activated protein kinase (MAPK) is one member of the MAPK family, which is activated in neurons and glia and contributes importantly to inflammatory and neuropathic pain. The aim of this review is to summarize the latest advances made about the implication of p38 MAPK signaling cascade in pain. It can deepen our understanding of the molecular mechanisms of pain and may help to offer new targets for pain treatment.
Identifiants
pubmed: 32485175
pii: S0024-3205(20)30635-4
doi: 10.1016/j.lfs.2020.117885
pii:
doi:
Substances chimiques
p38 Mitogen-Activated Protein Kinases
EC 2.7.11.24
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
117885Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.